Safety vs Price in the Generic Drug Market: Metformin
The American Journal of Managed Care · 01.04.2024 · 30 (4) · 161-168
DOI: 10.37765/ajmc.2024.89450 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Managed Care, online erschienen am 31.10.2023. Verfasst von Ben Teasdale und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Excellence Research Center, School of Medicine, Stanford University, 453 Quarry Rd #117B, CAM Building, Palo Alto, CA 94304. Email: kevin.sc…. Hauptthemen laut MEDLINE: Metformin. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Excellence Research Center, School of Medicine, Stanford University, 453 Quarry Rd #117B, CAM Building, Palo Alto, CA 94304. Email: kevin.schulman@stanford.edu.
Zitieren
APA
Teasdale, B., Hudspeth, A., Kucera, K., Light, D., Nailor, J., Williams, S., Milstein, A., & Schulman, K. A. (2024). Safety vs Price in the Generic Drug Market: Metformin. The American Journal of Managed Care, 30(4), 161-168. https://doi.org/10.37765/ajmc.2024.89450
Vancouver
Teasdale B, Hudspeth A, Kucera K, Light D, Nailor J, Williams S, et al. Safety vs Price in the Generic Drug Market: Metformin. The American Journal of Managed Care. 2024;30(4):161-168. doi:10.37765/ajmc.2024.89450
BibTeX
@article{Teasdale2024,
author = {Teasdale, Ben and Hudspeth, Amber and Kucera, Kaury and Light, David and Nailor, Jill and Williams, Shannon and Milstein, Arnold and Schulman, Kevin A},
title = {Safety vs Price in the Generic Drug Market: Metformin},
journal = {The American Journal of Managed Care},
year = {2024},
volume = {30},
number = {4},
pages = {161--168},
doi = {10.37765/ajmc.2024.89450}
}
EUVIMED